- Ayurcann Holdings Corp. (AYUR) has received its flower sales license amendment from Health Canada
- The Flower Sales License will allow Ayurcann to sell dried cannabis flower products in Canada through authorized distributors and retailers
- Ayurcann Holdings CEO Igal Sudman sat down with Coreena Robertson to discuss the news
- Ayurcann is a post-harvest solution provider with a focus on custom processes and pharma-grade products for Canada’s adult-use and medical cannabis industry
- Ayurcann Holdings Corp. (AYUR) opened trading at C$0.15 per share
Ayurcann Holdings Corp. (AYUR) has received its flower sales license amendment from Health Canada.
The Flower Sales License will allow Ayurcann to sell dried cannabis flower products in Canada through authorized distributors and retailers.
Ayurcann Holdings CEO Igal Sudman sat down with Coreena Robertson to discuss the news.
“With our specialty in extraction and Cannabis 2.0 brands in Vapes and Oils available throughout Canada, receiving the Flower Sales License is another avenue for Ayurcann to gather market share and pursue higher-margin growth within the cannabis market. With our current suppliers and large volume purchasing power we can leverage our current relationships by offering an expanded portfolio of other products targeted at the value conscious consumer. Our offerings will include pre-rolls and dried flower.”
Ayurcann is a post-harvest solution provider with a focus on custom processes and pharma-grade products for Canada’s adult-use and medical cannabis industries.
Ayurcann Holdings Corp. (AYUR) opened trading at C$0.15 per share.